DK0897914T3 - Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner - Google Patents

Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner

Info

Publication number
DK0897914T3
DK0897914T3 DK98114969T DK98114969T DK0897914T3 DK 0897914 T3 DK0897914 T3 DK 0897914T3 DK 98114969 T DK98114969 T DK 98114969T DK 98114969 T DK98114969 T DK 98114969T DK 0897914 T3 DK0897914 T3 DK 0897914T3
Authority
DK
Denmark
Prior art keywords
formula
compound
chem
signifies
preparation
Prior art date
Application number
DK98114969T
Other languages
English (en)
Inventor
Paul Spurr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0897914T3 publication Critical patent/DK0897914T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08—Preparation by ring-closure
    • C07D213/09—Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
    • C07D213/10—Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98114969T 1997-08-19 1998-08-10 Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner DK0897914T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97114269 1997-08-19

Publications (1)

Publication Number Publication Date
DK0897914T3 true DK0897914T3 (da) 2004-09-27

Family

ID=8227241

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98114969T DK0897914T3 (da) 1997-08-19 1998-08-10 Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner

Country Status (10)

Country Link
US (1) US6080866A (da)
EP (1) EP0897914B1 (da)
JP (1) JP3025239B2 (da)
KR (1) KR100275663B1 (da)
CN (1) CN1103335C (da)
AT (1) ATE267808T1 (da)
CA (1) CA2245169C (da)
DE (1) DE69824090T2 (da)
DK (1) DK0897914T3 (da)
ES (1) ES2221696T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6417360B1 (en) 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
ZA200002318B (en) * 1999-05-22 2000-11-16 Actelion Pharmaceuticals Ltd Aqueous pharmaceutical composition.
ES2918452T3 (es) * 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
NZ703163A (en) 2010-04-15 2016-06-24 Marinepolymer Tech Inc Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
EP2696680B1 (en) 2011-04-15 2018-11-28 Marine Polymer Technologies, Inc. Treatment of hsv infections with poly-n-acetyl glucosamine nanofibers
CA3197265A1 (en) 2020-11-05 2022-05-12 Timo Rager A stable crystalline hydrate of clazosentan disodium salt
EP4582086A3 (en) 2021-12-17 2025-07-23 Idorsia Pharmaceuticals Ltd Clazosentan disodium salt, its preparation and pharmaceutical compositions comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571683B2 (en) * 1984-05-23 1988-04-21 Zeneca Ag Products Inc. 2-substituted-5-methylpyridines from methylcyclobutane- carbonitrile, valeronitrile and pentenonitrile intermediates
DE4223013A1 (de) * 1992-07-13 1994-01-20 Bayer Ag Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
US5837708A (en) * 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
TW313568B (da) * 1994-12-20 1997-08-21 Hoffmann La Roche

Also Published As

Publication number Publication date
US6080866A (en) 2000-06-27
ES2221696T3 (es) 2005-01-01
CA2245169C (en) 2004-08-10
JP3025239B2 (ja) 2000-03-27
JPH11116554A (ja) 1999-04-27
CN1210105A (zh) 1999-03-10
CA2245169A1 (en) 1999-02-19
ATE267808T1 (de) 2004-06-15
KR19990023680A (ko) 1999-03-25
DE69824090D1 (de) 2004-07-01
CN1103335C (zh) 2003-03-19
KR100275663B1 (ko) 2000-12-15
EP0897914B1 (en) 2004-05-26
EP0897914A1 (en) 1999-02-24
DE69824090T2 (de) 2005-07-07

Similar Documents

Publication Publication Date Title
DK1254883T3 (da) Fremgangsmåde til fremstilling af substitueret 1,1,1-trifluoro-3-butene-2-oner
DK0629609T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
DK0733621T3 (da) Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
DK539589A (da) Fremgangsmaade til fremstilling af 3-oxo-4-azasteroider
GEP19970781B (en) Uracil derivatives
DE69824090D1 (de) Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
AU7810787A (en) 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
DE68920717D1 (de) Reaktivfarbstoffe.
DE3572816D1 (de) Pyridazinone inotropic agents
EP0435106A3 (en) Liquid crystal compound, liquid crystal composite including the compound and liquid crystal device utilizing the composite
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DK0579059T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
NO179408C (no) Flytende krystallblanding
DK193090A (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
EP0440136A3 (en) Liquid crystal composition and liquid crystal device containing the same
DK0412529T3 (da) Hidtil ukendte imidazolderivater, fremgangsmåde til fremstilling deraf og midler mod mavesår indeholdende disse
IL142760A0 (en) Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'-yl) amino]-cyclopent-2-enyl-methanols
DK0854135T3 (da) Fremgangsmåde til fremstilling af 2-cyanobiphenylforbindelser
TW368517B (en) Liquid crystal alkene-cyclohexene derivatives, liquid crystal composite and liquid crystal display component
DE58900084D1 (de) Azolylmethylcyclopropane und ihre verwendung als pflanzenschutzmittel.
ATE19241T1 (de) 4-aminomethyl-5-acyl-1,3-dihydro-imidazol-2-one
EP0147788A3 (en) Phenylacetanilide derivatives
DK0798296T3 (da) Fremgangsmåde til fremstilling af arylamider af heteroaromatiske carboxylsyrer